|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma M and Yu N: Ubiquitin-specific protease
7 expression is a prognostic factor in epithelial ovarian cancer
and correlates with lymph node metastasis. Onco Targets Ther.
9:1559–1569. 2016.PubMed/NCBI
|
|
4
|
Zhao GY, Lin ZW, Lu CL, Gu J, Yuan YF, Xu
FK, Liu RH, Ge D and Ding JY: USP7 overexpression predicts a poor
prognosis in lung squamous cell carcinoma and large cell carcinoma.
Tumour Biol. 36:1721–1729. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nathan JA, Sengupta S, Wood SA, Admon A,
Markson G, Sanderson C and Lehner PJ: The ubiquitin E3 ligase
MARCH7 is differentially regulated by the deubiquitylating enzymes
USP7 and USP9X. Traffic. 9:1130–1145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jelovac D and Armstrong DK: Recent
progress in the diagnosis and treatment of ovarian cancer. CA
Cancer J Clin. 61:183–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X and Zhang H: Diminished miR-613
expression as a novel prognostic biomarker for human ovarian
cancer. Eur Rev Med Pharmacol Sci. 20:837–841. 2016.PubMed/NCBI
|
|
9
|
Shichiri M, Ishimaru S, Ota T, Nishikawa
T, Isogai T and Hirata Y: Salusins: Newly identified bioactive
peptides with hemodynamic and mitogenic activities. Nat Med.
9:1166–1172. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Celik E, Celik O, Yilmaz E, Turkcuoglu I,
Karaer A, Turhan U and Aydin S: Association of low maternal levels
of salusins with gestational diabetes mellitus and with
small-for-gestational-age fetuses. Eur J Obstet Gynecol Reprod
Biol. 167:29–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sato K, Watanabe R, Itoh F, Shichiri M and
Watanabe T: Salusins: Potential use as a biomarker for
atherosclerotic cardiovascular diseases. Int J Hypertens.
2013:9651402013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Olson SH, Carlson MD, Ostrer H, Harlap S,
Stone A, Winters M and Ambrosone CB: Genetic variants in SOD2, MPO,
and NQO1, and risk of ovarian cancer. Gynecol Oncol. 93:615–620.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Celik Ö, Yılmaz E, Celik N, Minareci Y,
Turkcuoglu I, Simsek Y, Celik E, Karaer A and Aydin S: Salusins,
newly identified regulators of hemodynamics and mitogenesis,
increase in polycystic ovarian syndrome. Gynecol Endocrinol.
29:83–86. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sahin L, Bozkurt M, Celik O, Celik N,
Aydin S and Gencdal S: Serum salusins levels are increased and
correlated positively with cyst size in ovarian endometrioma.
Gynecol Endocrinol. 31:639–642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun HJ, Zhao MX, Ren XS, Liu TY, Chen Q,
Li YH, Kang YM, Wang JJ and Zhu GQ: Salusin-beta promotes vascular
smooth muscle cell migration and intimal hyperplasia after vascular
injury via ROS/NFkappaB/MMP-9 pathway. Antioxid Redox Signa.
24:1045–1057. 2016. View Article : Google Scholar
|
|
16
|
Sun HJ, Liu TY, Zhang F, Xiong XQ, Wang
JJ, Chen Q, Li YH, Kang YM, Zhou YB, Han Y, et al: Salusin-β
contributes to vascular remodeling associated with hypertension via
promoting vascular smooth muscle cell proliferation and vascular
fibrosis. Biochim Biophys Acta. 1852:1709–1718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun HJ, Zhang LL, Fan ZD, Chen D, Zhang L,
Gao XY, Kang YM and Zhu GQ: Superoxide anions involved in
sympathoexcitation and pressor effects of salusin-β in
paraventricular nucleus in hypertensive rats. Acta Physiol (Oxf).
210:534–545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang S and Liu W: Paeoniflorin inhibits
proliferation and promotes apoptosis of multiple myeloma cells via
its effects on microRNA-29b and matrix metalloproteinase-2. Mol Med
Rep. 14:2143–2149. 2016.PubMed/NCBI
|
|
19
|
Chen J, Wang S, Su J, Chu G, You H, Chen
Z, Sun H, Chen B and Zhou M: Interleukin-32α inactivates JAK2/STAT3
signaling and reverses interleukin-6-induced epithelial-mesenchymal
transition, invasion, and metastasis in pancreatic cancer cells.
Onco Targets Ther. 9:4225–4237. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shan S, Lv Q, Zhao Y, Liu C, Sun Y, Xi K,
Xiao J and Li C: Wnt/β-catenin pathway is required for epithelial
to mesenchymal transition in CXCL12 over expressed breast cancer
cells. Int J Clin Exp Pathol. 8:12357–12367. 2015.PubMed/NCBI
|
|
21
|
Xiao C, Wu CH and Hu HZ: LncRNA UCA1
promotes epithelial-mesenchymal transition (EMT) of breast cancer
cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med
Pharmacol Sci. 20:2819–2824. 2016.PubMed/NCBI
|
|
22
|
Cong J, Liu R, Wang X, Wang J, Wang H and
Hou J: Low miR-498 expression levels are associated with poor
prognosis in ovarian cancer. Eur Rev Med Pharmacol Sci.
19:4762–4765. 2015.PubMed/NCBI
|
|
23
|
Wan WN, Zhang YQ, Wang XM, Liu YJ, Zhang
YX, Que YH, Zhao WJ and Li P: Down-regulated miR-22 as predictive
biomarkers for prognosis of epithelial ovarian cancer. Diagn
Pathol. 9:1782014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren P, Yang XQ, Zhai XL, Zhang YQ and
Huang JF: Overexpression of Rab27B is correlated with distant
metastasis and poor prognosis in ovarian cancer. Oncol Lett.
12:1539–1545. 2016.PubMed/NCBI
|
|
25
|
Niepolski L and Grzegorzewska AE: Salusins
and adropin: New peptides potentially involved in lipid metabolism
and atherosclerosis. Adv Med Sci. 61:282–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu T, Zhang Z, Liu T, Zhang W, Liu J, Wang
W and Wang J: Salusin-β contributes to vascular inflammation
associated with pulmonary arterial hypertension in rats. J Thorac
Cardiovasc Surg. 152:1177–1187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu J, Ren YG, Zhang LH, Tong YW and Kang
L: Serum salusin-beta levels are associated with the presence and
severity of coronary artery disease. J Investig Med. 63:632–635.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu X and Sun S: RAD51 Gene 135G/C
polymorphism and ovarian cancer risk: A meta-analysis. Int J Clin
Exp Med. 8:22365–22370. 2015.PubMed/NCBI
|
|
29
|
Liu X and Li G: MicroRNA-133b inhibits
proliferation and invasion of ovarian cancer cells through Akt and
Erk1/2 inactivation by targeting epidermal growth factor receptor.
Int J Clin Exp Pathol. 8:10605–10614. 2015.PubMed/NCBI
|
|
30
|
Diepenbruck M and Christofori G:
Epithelial-mesenchymal transition (EMT) and metastasis: Yes, no,
maybe? Curr Opin Cell Biol. 43:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu Q, Deng F, Qin Y, Zhao Z, Wu Z, Xing Z,
Ji A and Wang QJ: Long non-coding RNA regulation of
epithelial-mesenchymal transition in cancer metastasis. Cell Death
Dis. 7:e22542016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kypta RM and Waxman J: Wnt/β-catenin
signalling in prostate cancer. Nat Rev Urol. 9:418–428. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoshida S, Furukawa N, Haruta S, Tanase Y,
Kanayama S, Noguchi T, Sakata M, Yamada Y, Oi H and Kobayashi H:
Expression profiles of genes involved in poor prognosis of
epithelial ovarian carcinoma: a review. Int J Gynecol Cancer.
19:992–997. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arend RC, Londoño-Joshi AI, Straughn JM Jr
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Boone JD, Arend RC, Johnston BE, Cooper
SJ, Gilchrist SA, Oelschlager DK, Grizzle WE, McGwin G Jr, Gangrade
A, Straughn JM Jr, et al: Targeting the Wnt/β-catenin pathway in
primary ovarian cancer with the porcupine inhibitor WNT974. Lab
Invest. 96:249–259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu H, Shi H, Fan Q and Sun X: Cyclin Y
regulates the proliferation, migration, and invasion of ovarian
cancer cells via Wnt signaling pathway. Tumour Biol.
37:10161–10175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bernaudo S, Salem M, Qi X, Zhou W, Zhang
C, Yang W, Rosman D, Deng Z, Ye G, Yang B, et al: Cyclin G2
inhibits epithelial-to-mesenchymal transition by disrupting
Wnt/β-catenin signaling. Oncogene. 35:4816–4827. 2016. View Article : Google Scholar : PubMed/NCBI
|
